Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease.
Diffusion MRI
Parkinson’s disease
magnetic resonance imaging (MRI)
metabolomics
oxidative stress
Journal
Journal of Parkinson's disease
ISSN: 1877-718X
Titre abrégé: J Parkinsons Dis
Pays: Netherlands
ID NLM: 101567362
Informations de publication
Date de publication:
2021
2021
Historique:
pubmed:
27
4
2021
medline:
1
2
2022
entrez:
26
4
2021
Statut:
ppublish
Résumé
Although pathological studies usually indicate pure dopaminergic neuronal degeneration in patients with parkin (PRKN) mutations, there is no evidence to date regarding white matter (WM) pathology. A previous diffusion MRI study has revealed WM microstructural alterations caused by systemic oxidative stress in idiopathic Parkinson's disease (PD), and we found that PRKN patients have systemic oxidative stress in serum biomarker studies. Thus, we hypothesized that PRKN mutations might lead to WM abnormalities. To investigate whether there are WM microstructural abnormalities in early-onset PD patients with PRKN mutations using diffusion tensor imaging (DTI). Nine PRKN patients and 15 age- and sex-matched healthy controls were recruited. DTI measures were acquired on a 3T MR scanner using a b value of 1,000 s/mm2 along 32 isotropic diffusion gradients. The DTI measures were compared between groups using tract-based spatial statistics (TBSS) analysis. Correlation analysis was also performed between the DTI parameters and several serum oxidative stress markers obtained in a previously conducted metabolomic analysis. Although the WM volumes were not significantly different, the TBSS analysis revealed a corresponding decrease in fractional anisotropy and an increase in mean diffusivity and radial diffusivity in WM areas, such as the anterior and superior corona radiata and uncinate fasciculus, in PRKN patients compared with controls. Furthermore, 9-hydroxystearate, an oxidative stress marker, and disease duration were positively correlated with several parameters in PRKN patients. This pilot study suggests that WM microstructural impairments occur in PRKN patients and are associated with disease duration and oxidative stress.
Sections du résumé
BACKGROUND
Although pathological studies usually indicate pure dopaminergic neuronal degeneration in patients with parkin (PRKN) mutations, there is no evidence to date regarding white matter (WM) pathology. A previous diffusion MRI study has revealed WM microstructural alterations caused by systemic oxidative stress in idiopathic Parkinson's disease (PD), and we found that PRKN patients have systemic oxidative stress in serum biomarker studies. Thus, we hypothesized that PRKN mutations might lead to WM abnormalities.
OBJECTIVE
To investigate whether there are WM microstructural abnormalities in early-onset PD patients with PRKN mutations using diffusion tensor imaging (DTI).
METHODS
Nine PRKN patients and 15 age- and sex-matched healthy controls were recruited. DTI measures were acquired on a 3T MR scanner using a b value of 1,000 s/mm2 along 32 isotropic diffusion gradients. The DTI measures were compared between groups using tract-based spatial statistics (TBSS) analysis. Correlation analysis was also performed between the DTI parameters and several serum oxidative stress markers obtained in a previously conducted metabolomic analysis.
RESULTS
Although the WM volumes were not significantly different, the TBSS analysis revealed a corresponding decrease in fractional anisotropy and an increase in mean diffusivity and radial diffusivity in WM areas, such as the anterior and superior corona radiata and uncinate fasciculus, in PRKN patients compared with controls. Furthermore, 9-hydroxystearate, an oxidative stress marker, and disease duration were positively correlated with several parameters in PRKN patients.
CONCLUSION
This pilot study suggests that WM microstructural impairments occur in PRKN patients and are associated with disease duration and oxidative stress.
Identifiants
pubmed: 33896850
pii: JPD202495
doi: 10.3233/JPD-202495
pmc: PMC8461664
doi:
Substances chimiques
Ubiquitin-Protein Ligases
EC 2.3.2.27
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1221-1235Références
Neurobiol Aging. 2019 Aug;80:56-70
pubmed: 31103633
Neuroimage. 2009 Jan 1;44(1):83-98
pubmed: 18501637
Parkinsonism Relat Disord. 2013 Apr;19(4):407-15
pubmed: 23462481
Neuroimage. 2006 Jul 15;31(4):1487-505
pubmed: 16624579
Brain. 2003 Jun;126(Pt 6):1279-92
pubmed: 12764051
Autophagy. 2009 Jul;5(5):706-8
pubmed: 19377297
J Neurol. 2018 Jan;265(1):52-62
pubmed: 29128929
Neuroimage. 2016 Jan 15;125:1063-1078
pubmed: 26481672
J Cell Biol. 2014 Sep 1;206(5):655-70
pubmed: 25154397
Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Neurotherapeutics. 2007 Jul;4(3):316-29
pubmed: 17599699
J Neural Transm (Vienna). 2017 Sep;124(9):1037-1054
pubmed: 28620835
Mol Psychiatry. 2018 Feb;23(2):459-466
pubmed: 28265121
J Neurol Sci. 2014 Nov 15;346(1-2):145-8
pubmed: 25194633
J Magn Reson Imaging. 2020 Dec;52(6):1620-1636
pubmed: 31837086
J Neurol. 2021 Sep;268(9):3203-3211
pubmed: 32436106
Neuroimage. 2014 May 15;92:381-97
pubmed: 24530839
Biophys J. 1994 Jan;66(1):259-67
pubmed: 8130344
JAMA Neurol. 2013 May;70(5):571-9
pubmed: 23459986
Brain Res. 2001 Feb 23;892(2):329-35
pubmed: 11172780
Cell Metab. 2017 Jan 10;25(1):57-71
pubmed: 28094012
Mov Disord. 2013 Mar;28(3):388-91
pubmed: 23401296
Nat Rev Dis Primers. 2017 Mar 23;3:17013
pubmed: 28332488
CNS Neurosci Ther. 2018 Feb;24(2):108-114
pubmed: 29125694
Neuroradiology. 2014 Mar;56(3):251-8
pubmed: 24468858
Eur Radiol. 2013 Jul;23(7):1946-55
pubmed: 23404139
J Mol Neurosci. 2020 Feb;70(2):246-253
pubmed: 31927768
Neuroimage Clin. 2017 Jul 15;16:98-110
pubmed: 28765809
Neuroimage. 2012 Jun;61(2):324-41
pubmed: 22120012
Oxid Med Cell Longev. 2017;2017:7371403
pubmed: 28232858
J Neurol Neurosurg Psychiatry. 2016 Mar;87(3):295-301
pubmed: 25795009
Sci Rep. 2018 Oct 26;8(1):15898
pubmed: 30367110
Neurology. 1998 Sep;51(3):890-2
pubmed: 9748052
AJNR Am J Neuroradiol. 2012 May;33(5):890-5
pubmed: 22241380
J Neural Transm (Vienna). 2017 Apr;124(4):407-415
pubmed: 28160151
Nature. 1998 Apr 9;392(6676):605-8
pubmed: 9560156
Nature. 2019 Jul;571(7764):183-192
pubmed: 31292558
Behav Brain Res. 2017 Jun 30;329:111-119
pubmed: 28457881
Neuroimage. 2008 Nov 15;43(3):447-57
pubmed: 18692144
Ann Clin Transl Neurol. 2019 Feb 21;6(3):525-536
pubmed: 30911576
Neuroimage. 2002 Nov;17(3):1429-36
pubmed: 12414282
Ann Clin Transl Neurol. 2020 Mar;7(3):307-317
pubmed: 32059082
Psychol Bull. 1992 Jul;112(1):155-9
pubmed: 19565683
Nat Genet. 2000 Jul;25(3):302-5
pubmed: 10888878